Rheumatologist perspective of the Brazilian consensus for detection of auto antibodies in HEp-2 CELLS

ObjectiveTo evaluate the perception of rheumatologists regarding the recommendations of the Brazilian Consensus for detection of Autoantibodies (BCA) on HEp-2 Cells by Indirect Immunofluorescence assay (IFA) and how BCA recommendations help in clinical practice.MethodologyA structured questionnaire regarding the BCA recommendations for detection and interpretations of autoantibodies in HEp-2 cells was applied to randomly selected rheumatologists. The results were tabulated using the Microsoft (R) Excel program, expressed as a simple percentage and the dichotomous data were analyzed using the Chi-square test and the Epi Info (R) program.ResultsFour hundred fuorteen rheumatologists participated in the study: 70% of them considered their knowledge of the HEp-2 IFA test satisfactory or excellent, and 43% said they knew the BCA recommendations in general, without distinguishing the edition of the BCA to which they refer. The Revista Brasileira de Rheumatologia/Advances in Rheumatology was the means of dissemination most consulted by specialists (50%). According to the rheumatologists' opinion, the most relevant pattern was the homogeneous nuclear (78%) and 65% stated they were satisfied with the BCA recommendations at a level of satisfaction greater than or equal to 80%. There was no significant difference in the perception of rheumatologists from the several Brazilian geographic regions.ConclusionBrazilian rheumatologists are aware of the BCA guidelines and most are satisfied with the content published, considering that the BCA recommendations assist positively in the clinical practice. Most rheumatologists recognize the patterns associated with rheumatic autoimmune diseases and have used BCA recommendations to interpret the results of the HEp-2 IFA test.

Automated summary

This study evaluated the perception of Brazilian rheumatologists on the BCA recommendations for detection of autoantibodies in HEp-2 cells. The majority of rheumatologists were satisfied with the BCA guidelines and believed that they positively impact clinical practice by helping interpret the results of the HEp-2 IFA test.